会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 145. 发明公开
    • NOVEL COMPLEXES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL USE OF THEM
    • NEUE KOMPLEXE DEREN HERSTELLUNG UND VERWENDUNG ALS ARZNEIMITTEL。
    • EP0270682A1
    • 1988-06-15
    • EP87903416.3
    • 1987-05-20
    • KURARAY CO., LTD.
    • MORI, FumioOKADA, MasafumiMIKI, ShujiEBASHI, IwaoNISHIDA, TakashiKAWAI, KouichiroTASHIRO, TazukoTSUKAGOSHI, Shigeru
    • A61K31/725C08B37/00
    • C08B37/0018
    • Pullulans having active sites formed by sulfation, phosPhorylation, sulfonation or carboxylation or their pharmacologically acceptable salts, wherein one hydrogen atom of the active sites represented by formula (I), partially sub- stituted by a group represented by the general formula (II), (wherein L 1 and L 2 each represents amine or unidentate amine or when taken together, represent bidentate amine. and Y represents an anionic ligand) and/or two hydrogen atoms or the active sites represented by formula (III) or of two formula (IV) groups bound to the same carbon atom or adjacent carbon atoms are partially substituted by a group represented by the formula (V), (wherein L' and L 2 are the name as defined above). These compounds have an onco- static activity and are useful as oncostatic agents. Process for their preparation and their medicinal use are also dis- closed
    • 支链淀粉铂络合物是新的,其中支链淀粉具有式(Ia),(Ib),(Ic)或(Id)的活性位点:这些活性位点中的一些或全部的一个氢原子被一组式 (IIa)或(IIb):(其中L1和L2各自为氨或异齿胺,或一起为二齿胺; Y为阴离子配体); 或在(Ic)的情况下,两个氢原子可以被式(IV)的基团取代; 或两个相邻(Id)的氢原子可以被(IV)代替。 制备是通过支链淀粉的硫酸化,磺化,磷酸化或羧化,随后与式(III)的铂化合物反应:(其中X 1和X 2是硝基,或一个是硝基,另一个是羟基或硫酸根)。
    • 147. 发明公开
    • 가돌리늄 착물, 그 제조방법, 및 그것을 포함하는 MRI 조영제
    • GADOLINIUM复合物,其制备方法和包括其的MRI对比剂
    • KR1020100120971A
    • 2010-11-17
    • KR1020090039883
    • 2009-05-07
    • 가톨릭대학교 산학협력단
    • 나건임현아
    • C07F5/00A61K49/06
    • A61K49/128C08B37/0018
    • PURPOSE: A gadolinium complex and MRI contrast medium composition containing the same are provided to ensure low toxicity and long half-life. CONSTITUTION: A gadolinium complex is formed by coordinate bond of gadolinium to pullulan-DTPA formed by ester bond pullulan and DTPA(diethylene triamine pentacetic acid dianhydride). A method for preparing the gadolinium complex comprises: a step of dissolving pullulan and DTPA in an organic solvent to obtaining pullulan-DTPA assembly by ester bond; a step of mixing the solution of pullulan-DTPA assembly; and a step of adjusting pH concentration by 5-7. An MRI contrast agent composition contains the gadolinium complex.
    • 目的:提供含有钆络合物和MRI造影剂组合物以确保低毒性和长半衰期。 构成:钆络合物通过咔唑的配位键与由酯键支链淀粉和DTPA(二亚乙基三胺五乙酸二酐)形成的支链淀粉-DTPA形成。 制备钆络合物的方法包括:将支链淀粉和DTPA溶解在有机溶剂中以通过酯键获得支链淀粉-DTPA组装的步骤; 混合支链淀粉-DTPA组合物的一个步骤; 以及将pH浓度调节5-7的步骤。 MRI造影剂组合物含有钆络合物。